Eventide
North America, Massachusetts, United States, Boston
Description
Eventide is an asset management company that provides investment services for individuals, financial advisors, and institutions.
Investor Profile
Eventide has backed more than 49 startups, with 5 new investments in the last 12 months alone. The firm has led 13 rounds, about 27% of its total and boasts 23 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Led 2 rounds in the past year.
Stage Focus
- Series B (37%)
- Series C (24%)
- Post Ipo Equity (12%)
- Series D (6%)
- Private Equity (6%)
- Series Unknown (6%)
- Series A (4%)
- Series E (4%)
Country Focus
- United States (92%)
- Switzerland (4%)
- United Kingdom (2%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- France (2%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Medical Device
- Life Science
- Biopharma
- Pharmaceutical
- Health Diagnostics
- Diabetes
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
